Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,743 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06754098RecruitingPhase 2
Testing two drugs for TK2 deficiency
This trial tests two experimental drugs, Doxecitin and Doxribthymine, for adults with a rare genetic condition called TK2 deficiency that causes muscle weakness and breathing problems. The goal is to see if these drugs can slow or stop the disease.
MadridAges 18 years+ - NCT06754280Recruiting
Sitting less for Black adults with chronic kidney disease
This study tests a program to help Black adults with chronic kidney disease sit less and move more throughout the day. You might join if you spend 6 or more hours sitting each day and can walk and stand without help.
Chicago, IllinoisAges 35–80 - NCT06754891RecruitingPhase 1
A study of TQH3906 for moderate to severe inflammatory bowel disease
This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.
Bengbu, AnhuiAges 18–75 - NCT06756152RecruitingPhase 2/Phase 3
Preventing GVHD after transplant for blood cancers in children and young adults
This trial tests a combination of four medicines (cyclophosphamide, abatacept, vedolizumab, and ruxolitinib) to prevent graft-versus-host disease (GVHD) after a stem cell transplant for children and young adults with certain blood cancers. The goal is to see if this approach reduces the risk of GVHD, a serious complication where donor cells attack the body.
MoscowAges 1 day–21 years - NCT06756932RecruitingPhase 1
Bcl-2 inhibitor combo for advanced HR+ breast cancer
This trial tests a new Bcl-2 inhibitor (BGB-21447) combined with other therapies for advanced HR+/HER2- breast cancer that has already been treated with hormone therapy and a CDK4/6 inhibitor. It aims to see if these combinations are safe and effective.
Iowa City, IowaAges 18 years+ - NCT06760273Recruiting
Tobramycin for Pseudomonas infection in bronchiectasis
This study looks at the long-term effects of using an inhaled antibiotic called tobramycin to get rid of Pseudomonas aeruginosa bacteria in people with bronchiectasis. It may help keep the infection away and improve breathing health.
Hefei, AnhuiAges 18–80 - NCT06764615RecruitingPhase 2
Long-term study of TAK-279 for ulcerative colitis and Crohn's disease
This study is for people who already completed 52 weeks of treatment with TAK-279 for ulcerative colitis or Crohn's disease and saw improvement. It gives them the option to continue the medication long-term to see if the benefits last.
Glen Burnie, MarylandAges 18–75 - NCT06764693Recruiting
Study on treatment with Risankizumab for psoriatic arthritis
This study tests how well a medicine called Risankizumab works for people with psoriatic arthritis. It is for adults who have had symptoms for at least 6 months and have not had enough help from at least one other arthritis medicine.
Quilmes, Buenos AiresAges 18–75 - NCT06764706Recruiting
Risankizumab for moderate-to-severe ulcerative colitis
This study observes how well risankizumab works for people with moderate to severe ulcerative colitis who are already starting it as part of their regular care. It helps doctors learn more about the drug's real-world effects.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT06770374Recruiting
Zinc oxide adhesive for IV line securement
This trial tests a special adhesive dressing made with zinc oxide to keep your IV line secure. It looks at whether this dressing helps prevent the line from moving, which could reduce complications.
Lleida, CataloniaAges 18 years+ - NCT06770764RecruitingPhase 1
Testing ODC-IL2 for advanced solid tumors
This trial tests a new drug called ODC-IL2 for people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to help your immune system fight cancer. The study starts with small doses to find the best dose, then expands to see how well it works.
Scottsdale, ArizonaAges 18 years+ - NCT06775639Recruiting
Can we skip a heart artery test before surgery?
This study looks at whether people with adult congenital heart disease can skip a pre-surgery artery test (coronary angiography) if they already had a CT scan. If you qualify, you might help doctors find safer, simpler ways to prepare for heart surgery.
BolognaAges 18 years+ - NCT06777628Recruiting
Blood test study to predict immunotherapy success in liver cancer
This study looks at blood cells from people with liver cancer (HCC) to see if we can predict early whether immunotherapy will work for them. It's a research study that involves blood tests during your normal care.
Bologna, Laura GramantieriAges 18 years+ - NCT06778863RecruitingPhase 1
A study of CLSP-1025 for adults with certain solid tumors
This trial tests a new drug called CLSP-1025 for people with advanced solid tumors that have a specific change in the p53 gene (R175H). The drug targets this change to help fight the cancer.
Scottsdale, ArizonaAges 18 years+ - NCT06780670RecruitingPhase 2/Phase 3
Comparing a new drug to standard care for prostate cancer
This trial tests a new study drug (AAA817) against the usual treatments for men with a certain type of advanced prostate cancer that has spread and is no longer responding to a targeted radiation therapy (177Lu-PSMA). The goal is to see if the new drug can help control the disease longer.
Los Angeles, CaliforniaAges 18–100 - NCT06780917Recruiting
Online cognitive testing for older adults with depression or memory concerns
This study tests whether an online cognitive assessment platform (Creyos) is valid for older adults with major depression or mild cognitive impairment. Participants will complete brain games or puzzles to see how well the online tool measures thinking skills.
Toronto, OntarioAges 60 years+ - NCT06781749Recruiting
Measuring social engagement in older adults with hearing loss
This study tests a new way to objectively measure how socially engaged older adults with hearing loss are. It may help researchers better understand the impact of hearing loss on social participation.
Los Angeles, CaliforniaAges 60 years+ - NCT06785181Recruiting
Heart-brain health in healthy adults
This study looks at how the heart, blood vessels, and brain work together in healthy adults. It may help us understand normal body function.
San Donato Milanese, MilanoAges 18 years+ - NCT06785324Recruiting
Nutrition and exercise for adults with ALL in the hospital
This trial tests whether adding a structured diet and exercise program during your hospital stay for newly diagnosed ALL can help your recovery. You must have a specific type of ALL and be receiving a certain chemotherapy regimen.
Chicago, IllinoisAges 18–50 - NCT06786234RecruitingPhase 2
STP938 for high-risk essential thrombocythemia
This trial tests a daily pill called STP938 (dencatistat) for people with high-risk essential thrombocythemia (ET) who cannot take or have stopped responding to hydroxycarbamide. The goal is to see if STP938 can safely lower your platelet count and control the condition.
Poitiers, New AquitaineAges 18 years+ - NCT06786364Recruiting
Measuring blood flow waves in sepsis patients
This study uses a special light sensor to measure blood flow waves in patients with septic shock. The goal is to see if these waves can help doctors understand how severe the shock is.
Mexico City, CuauhtemocAges 18 years+ - NCT06786416Recruiting
Monitoring to prevent kidney injury after heart surgery
This trial is testing a new monitoring system that tracks blood flow and other vital signs during heart surgery to help prevent kidney damage afterward.
San Donato Milanese, MilanoAges 18 years+ - NCT06787820Recruiting
Music intervention for seniors in assisted living
This study tests whether a musical activity program can improve well-being in older adults living in a protected residence. It is designed for seniors who can join in music sessions and who do not have significant memory or thinking problems.
Santiago, Santiago MetropolitanAges 65 years+ - NCT06789666Recruiting
Digital art therapy for young cancer survivors
This trial is testing a digital art therapy program designed to help young adults who survived childhood cancer feel better emotionally. You'll use an app to create art and connect with others, all from home.
Chapel Hill, North CarolinaAges 18–25
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,743 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.